Fennec Pharmaceuticals (FENC)

• Market cap: $346M
• 1 day: 0.81%
• 5 days: 1.84%
• 1 month: 45.55%
• 3 months: 17.43%
• 6 months: 21.73%
• Year to date: 29.82%
• 1 year: 22.63%
• 5 years: 44.28%
• 10 years: -16.92%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 35